
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $3.3B | $3.5B | $3.2B | $812.3M | $849.8M | |
Gross Profit | $1.4B | $1.5B | $1.5B | $344.7M | $387.3M | |
Operating Income | $480M | $429.6M | $402.5M | $81.4M | $51.2M | |
EBITDA | $739.1M | $872.2M | $915.5M | $187.9M | $259.5M | |
Diluted EPS | $1.53 | $1.19 | $1.93 | $0.25 | $0.67 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $1.2B | $1.3B | $2.3B | $2B | $1.6B | |
Total Assets | $2.9B | $3.2B | $10.1B | $8.8B | $8.4B | |
Current Liabilities | $302.6M | $379M | $761.9M | $514M | $525.2M | |
Total Liabilities | $1.5B | $1.5B | $6.9B | $5.4B | $4.7B | |
Total Equity | $1.4B | $1.7B | $3.2B | $3.4B | $3.7B | |
Total Debt | $1.1B | $937M | $5.8B | $4.6B | $4B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $363.1M | $644.5M | $631.7M | $158.1M | $176.1M | |
Cash From Investing | -$4.9B | $553.1M | -$67.1M | $575.8M | -$107.9M | |
Cash From Financing | $4.8B | -$1.3B | -$689M | -$880.1M | -$165.4M | |
Free Cash Flow | -$103.1M | $187.6M | $316.1M | $29.4M | $68.6M |
Entegris Inc is a supplier of materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include The Materials Solutions segment which provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The Advanced Purity Solutions segment offers filtration, purification and contamination-control solutions that improve customers’ yield, device reliability and cost by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates.
In the current month, ENTG has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ENTG average analyst price target in the past 3 months is $128.15.
According to analysts, the consensus estimate is that Entegris share price will rise to $128.15 per share over the next 12 months.
Analysts are divided on their view about Entegris share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Entegris is a Sell and believe this share price will drop from its current level to $115.00.
The price target for Entegris over the next 1-year time period is forecast to be $128.15 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
According to Wall Street analysts, the consensus rating for Entegris is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
You can purchase shares of Entegris via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Entegris shares.
Entegris was last trading at $95.29 per share. This represents the most recent stock quote for Entegris. Yesterday, Entegris closed at $95.31 per share.
In order to purchase Entegris stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
For the last few years, earnings growth from the tech…
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Market Cap: $3.3T
P/E Ratio: 36x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.7T
P/E Ratio: 37x
Guardant Health [GH] is up 1.1% over the past day.
Teradyne [TER] is down 0.36% over the past day.
Limbach Holdings [LMB] is down 4.39% over the past day.